Skip to main content
Caplight Logo









Eolas Medical

Eolas Medical

Private
BelfastHealthcare & Life Scienceshttps://eolasmedical.com/en-us

Last Round

Series A

Jan 19, 2026

Est. Valuation

$40.38M

Total Funding Raised

$14.75M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Eolas Medical is a health-tech company that provides an AI-enabled clinical knowledge infrastructure platform to help healthcare systems and clinicians access institution-specific guidelines and protocols at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical knowledge managementclinical decision supportCDSSclinical guidelinespoint of carehealthcare SaaSclinical governancemedical protocol managementclinical workflow automationhospital softwareAI clinical assistantdigital health platformmedical knowledge baseclinical documentationmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eolas Medical Comparables

Compare Eolas Medical with similar companies based on industry and business-model similarity.

Eolas Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wolters Kluwer
74%
British Medical Association
71%
EvidenceCare
69%

Eolas Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 19, 2026
SeedMar 12, 2021

Eolas Medical Investors

Notable investors and investment history

Eolas Medical investors
InvestorRounds
Ascension VenturesSeries A, Seed
ScaleX InvestmentsSeries A
Whiterock Capital PartnersSeries A
Portfolio VenturesSeries A
SamaipataSeries A, Seed
7 Percent VenturesSeed
Acton CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2026

    Grew 33% QoQ, from 15 to 20 employees.

  • May 11, 2026

    Grew 111% QoQ, from 9 to 19 employees.

Eolas Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Eolas Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Eolas Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelfast
Employee Range20
Year Founded2019
Last FundingJan 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?